Evidence map›Paper›PMID 27793485›Full record

GuidelineVaccine2016

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.

Christine E Jones, Flor M Munoz, Sonali Kochhar, Stefania Vergnano, Clare L Cutland, Mark Steinhoff, Steven Black, Ulrich Heininger, Jan Bonhoeffer, Paul T Heath

Registry-linked trialOpen access · hybridAbstract readGuideline
In one paragraph

Guideline in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05808166 (A Phase II, Randomized, Observer-blinded, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women Between Gestational Age 14-34 Weeks and Non-Pregnant Women of 16-45 Years Old.), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05808166 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

A Phase II, Randomized, Observer-blinded, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women Between Gestational Age 14-34 Weeks and Non-Pregnant Women of 16-45 Years Old.

TypeinterventionalSponsorInternational Vaccine InstituteRan2024 to 2026Enrolled2,358ConditionsHepatitis E InfectionArmsHecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride injection
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Christine E JonesPaediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, UK. Electronic address: contact@brightoncollaboration.org.
Flor M MunozBaylor College of Medicine, Houston, TX, USA.
Sonali KochharGlobal Healthcare Consulting, India.
Stefania VergnanoPaediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, UK; School of Clinical Sciences, University of Bristol, UK.
Clare L CutlandMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, South Africa; Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, South Africa.
Mark SteinhoffCincinnati Children's Hospital Medical Center, USA.
Steven BlackCenter for Global Health, Cincinnati Children's Hospital, USA.
Ulrich HeiningerUniversity of Basel Children's Hospital, Basel, Switzerland.
Jan BonhoefferUniversity of Basel Children's Hospital, Basel, Switzerland.
Paul T HeathPaediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, UK.
St George's, University of London · GBCincinnati Children's Hospital Medical Center · USBaylor College of Medicine · USRespiratory and Meningeal Pathogens Research Unit · ZAUniversity Children’s Hospital Basel · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection and reporting of critical data to allow comparisons and data pooling becomes more important. The Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project aims to improve data collection and create a shared understanding of maternal, fetal and neonatal outcomes in order to progress the global agenda for vaccination in pregnancy. The guidance in this document has been developed to harmonize the data collected in case report forms used for safety monitoring in clinical trials of vaccination in pregnant women. Data to be collected is prioritized to allow applicability in diverse research settings, including low and middle-income countries. Standardized data will enable the research community to have a common base upon which to conduct meta-analyses, strengthening the applicability of outcomes to different settings.

Indexed as

Data CollectionPregnancyClinical Trials as TopicDrug-Related Side Effects and Adverse ReactionsFemaleGlobal HealthHumansInfantPovertyPregnancy Complications, InfectiousRecordsStatistics as TopicVaccinationVaccinesVaccinesAdverse eventCase report formClinical trialsGuidanceImmunizationPregnancySafetyVaccines

Identifiers

PMID27793485
PMCPMC5139802
OpenAlexW2536757210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.